A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
2,5-Dimethoxyamphetamine
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Lasmiditan.
2,5-Dimethoxyamphetamine
Favipiravir
The serum concentration of Lasmiditan can be increased when it is combined with Favipiravir.
2,5-Dimethoxyamphetamine
Entrectinib
The serum concentration of Lasmiditan can be increased when it is combined with Entrectinib.
2,5-Dimethoxyamphetamine
ONT-093
The serum concentration of Lasmiditan can be increased when it is combined with ONT-093.
2,5-Dimethoxyamphetamine
Laniquidar
The serum concentration of Lasmiditan can be increased when it is combined with Laniquidar.
2,5-Dimethoxyamphetamine
Sarecycline
The serum concentration of Lasmiditan can be increased when it is combined with Sarecycline.
2,5-Dimethoxyamphetamine
Neratinib
The serum concentration of Lasmiditan can be increased when it is combined with Neratinib.
2,5-Dimethoxyamphetamine
Istradefylline
The serum concentration of Lasmiditan can be increased when it is combined with Istradefylline.
2,5-Dimethoxyamphetamine
Brefeldin A
The serum concentration of Lasmiditan can be increased when it is combined with Brefeldin A.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3